Skip to main content

Table 1 Characteristics of patients with early stage pancreatic cancer (N = 49)

From: Surgery for elderly patients with resectable pancreatic cancer, a comparison with non-surgical treatments: a retrospective study outcomes of resectable pancreatic cancer

Factors

Surgery (N = 38)

No surgery (N = 11)

P value

Sex

  

.55

 Male

24 (63.2%)

8 (72.7%)

 

 Female

14 (36.8%)

3 (27.3%)

 

Age (mean, range)

78 (75–87)

80 (75–86)

.07

BMI (mean, range)

21.8 (17.5–26.8)

22.0 (17.4–25.4)

.81

Smoking

  

.06

 Yes

9 (23.7%)

5 (55.6%)

 

 No

29 (76.3%)

4 (44.4%)

 

Alcohol

  

.46

 Yes

12 (31.6%)

4 (44.4%)

 

 No

26 (68.4%)

5 (55.6%)

 

HTN

  

1.00

 Yes

19 (50%)

5 (50%)

 

 No

19 (50%)

5 (50%)

 

DM

  

.25

 Yes

19 (50%)

3 (30%)

 

 No

19 (50%)

7 (70%)

 

Charlson comorbidity Index

  

.92

 0

16 (42.1%)

5 (45.5%)

 

 1

14 (36.8%)

4 (36.4%)

 

 2

6 (15.8%)

1 (9.1%)

 

 3

2 (5.3%)

1 (9.1%)

 

ECOG PS

  

.19

 0

9 (23.7%)

2 (18.2%)

 

 1

26 (68.4%)

6 (54.5%)

 

 2

3 (7.9%)

2 (18.2%)

 

 3

0

1 (9.1%)

 

Family Hx. of malignancy

  

.12

 Yes

7 (18.4%)

0

 

 No

31 (81.6%)

11 (100%)

 

Location of tumor

  

.85

 Head

26 (68.4%)

8 (72.7%)

 

 Body & Tail

12 (31.6%)

3 (27.3%)

 

Preoperative data (median ± SD)

 Hb (g/dL)

12.5 ± 1.5

13.0 ± 2.0

.46

  INR

1.04 ± 0.19

1.10 ± 0.12

.57

  T. Bil

0.8 ± 3.3

0.7 ± 1.1

.17

 Albumin (g/dL)

4.1 ± 0.4

4.1 ± 0.4

.54

 CA 19–9 (U/mL)

175.0 ± 713.8

169.2 ± 663.2

.98

TNM Staging

  

.32

 1

3 (7.9%)

2 (18.2%)

 

 2

35 (92.1%)

9 (81.8%)

 

CTx. and/or RTx.

  

.95

 Yes

10 (26.3%)

3 (27.3%)

 

 No

28 (73.7%)

8 (72.7%)

 
  1. BMI body mass index, ECOG Eastern Cooperative Oncology Group, PS performance status, Hx. history, SD standard deviation, Hb hemoglobin, INR international normalized ratio, T. Bil total bilirubin, CA 19–9 carbohydrate antigen 19–9, CTx. chemotherapy, RTx. radiotherapy